Skip to main content

Table 5 [Baseline] demographic and clinical characteristics between two treatment groups of clomiphene-metformin combination

From: Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism

Item

Group I (Clomiphene and Metformin)

Group II (Clomiphene alone)

P-value

N

37

36

 

Age (years)

28.86 ± 0.53

27.36 ± 0.65

0.08

BMI (Kg/m2)

25.13 ± 0.36

25.08 ± 0.30

0.91

Duration of infertility (years)

2.17 ± 0.2277

1.911 ± 0.2116

0.42

Spontaneous menstrual cycle interval (months)

3.42 ± 0.38

2.66 ± 0.34

0.14

Menstrual flow length (days)

6.62 ± 0.55

6.53 ± 0.53

0.90

HbA1c (%)

5.79 ± 0.04

5.74 ± 0.05

0.53

HOMA-IR

3.30(2.56, 4.49)

3.42(2 .78, 3.91)

0.72